HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Johnson & Johnson

http://www.jnj.com

Latest From Johnson & Johnson

M&A Activity During Q2 Declined In Volume And Valuation

Following a pair of $10bn+ deals in Q4 2023 and a $16.5bn takeout in Q1, the second quarter saw no acquisition priced as high as $5bn, Evaluate notes. Aggregate deal volume and values dropped from Q1.

Evaluate Data M & A

Will US Clinical Study Diversity Guidance Cloud Chinese Firms’ Prospects For Going Global?

The latest FDA guidance will have profound impact to Chinese biotech sector at a time when going global and a US approval is vital to its very survival.

Diversity & Inclusion Clinical Trials

IPOs Collapse In The Second Quarter

Biotechs have had a difficult time raising cash through flotations over the past quarter, with one stepping away altogether.

Financing Business Strategies

New Oncologics Overwhelmingly Approved In US Before EU

Ninety-five percent of novel cancer treatments approved in both the US and Europe received the FDA’s OK first, but Europe usually followed within a year, a Pink Sheet analysis shows.

Regional Comparisons Approvals
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Medical Devices
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Abiomed, Inc.
    • Acclarent Inc.
    • Actelion Pharmaceuticals Ltd.
    • AdvanceCOR GmbH
    • ALZA Corporation
    • Alios BioPharma, Inc.
    • Animas Corporation
    • Aragon Pharmaceuticals, Inc.
    • Auris Health, Inc.
    • Auris Surgical Robotics
    • BeneVir Biopharm, Inc.
    • BioMedical Enterprises, Inc.
    • Biosense Webster, Inc.
    • Calibra Medical, Inc.
    • Centyrex Internal Venture
    • Cilag AG
    • Cerenovus
    • Codman & Shurtleff, Inc
    • Coherex Medical, Inc.
    • Conor Medsystems, Inc.
    • Cordis Webster, Inc.
    • CorImmun GmbH
    • Cougar Biotechnology, Inc.
    • Covagen AG
    • Crucell N.V.
    • DePuy Mitek, Inc.
    • DePuy Orthopaedics, Inc.
    • DePuy Synthes, Inc.
    • Ensure Medical
    • Ethicon, Inc.
    • FemRx Inc.
    • Flexible Stenting Solutions, Inc.
    • Gynecare, Inc.
    • Hansen Medical, Inc.
    • Innovative Surgical Solutions, LLC
    • Interventional Spine, Inc.
    • Janssen Biotech, Inc. (formerly Centocor Ortho Biotech Inc.)
    • Janssen Diagnostics
    • Janssen Pharmaceuticals
    • Janssen Vaccines & Prevention B.V.
    • JointPoint, Inc.
    • LifeScan, Inc.
    • Medical Enterprises Distribution, LLC
    • Medos International SARL
    • Megadyne Medical Products, Inc.
    • Mentor Corporation
    • Micrus Endovascular Corporation
    • Molsaic Internal Venture
    • Momenta Pharmaceuticals, Inc.
    • NeoStrata Company, Inc.
    • Neuravi Limited
    • NeuWave Medical, Inc.
    • Novira Therapeutics
    • Omrix Biopharmaceuticals, Inc.
    • Ortho Biotech Products, L.P.
    • Ortho-McNeil, Inc.
    • Orthotaxy
    • Peninsula Pharmaceuticals, Inc.
    • Pulsar Vascular Inc
    • RespiVert Ltd.
    • Scios, Inc.
    • Selected Nerve Stimulation Internal Ventures
    • Sentio, LLC
    • Sequus Pharmaceuticals
    • Stem Cell Internal Venture
    • Synthes, Inc.
    • Tibotec
    • Torax Medical, Inc.
    • Triage Medical, Inc.
    • Verb Surgical Inc.
    • Veridex
    • Vigor Sub, Inc.
    • Vistakon
    • XO1 Limited
    • TARIS Biomedical LLC
    • Verb Surgical, Inc.
UsernamePublicRestriction

Register